Primary Venous Thromboembolism Prophylaxis in Ambulatory Cancer Patients (February).

February 5, 2013, from MedWorm: Brain Tumor

CONCLUSIONS:Use of antithrombotic agents has reduced the rate of primary VTE, with minimal increases in bleeding risk in specific ambulatory cancer populations. Further investigation is needed to guide and narrow recommendations for primary VTE prophylaxis in ambulatory cancer patients. PMID: 23386067 [PubMed - as supplied by publisher] (Source: The Annals of Pharmacotherapy)

MedWorm Sponsor Message: Have a look at The Cancer and Oncology Daily, the new cancer portal with all the latest cancer news and research powered by MedWorm, updated daily.

View Source